Idexx Laboratories (IDXX) Gross Profit (2009 - 2026)

Idexx Laboratories' Gross Profit history runs 18 years deep, the most recent figure standing at $722.7 million for Q1 2026.

• In Q1 2026, Gross Profit rose 15.94% year-over-year to $722.7 million; the TTM figure through Mar 2026 stood at $2.8 billion (up 14.52% YoY), while the FY2025 annual figure was $2.7 billion, up 11.8% from the prior year.
• Gross Profit was $722.7 million for Q1 2026 at Idexx Laboratories, up from $658.1 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $722.7 million in Q1 2026 to a low of $484.9 million in Q4 2022.
• Historically, Gross Profit has averaged $585.6 million across 5 years, with a median of $572.8 million in 2023.
• The sharpest annual moves came in 2022 and 2026: Gross Profit advanced 5.05% in 2022, then climbed 15.94% in 2026.
• A 5-year view of Gross Profit shows it stood at $484.9 million in 2022, then gained by 8.5% to $526.2 million in 2023, then climbed by 8.46% to $570.7 million in 2024, then increased by 15.33% to $658.1 million in 2025, then gained by 9.82% to $722.7 million in 2026.
• The last three Gross Profit figures came in at $722.7 million (Q1 2026), $658.1 million (Q4 2025), and $683.4 million (Q3 2025), per Business Quant data.